Giulia C. Kennedy is Chief Scientific & Med Officer at VERACYTE, INC. (VCYT). They have made 21 open-market trades across 1 company since 2019, most recently 2022-12-06.
CIK 0001769333
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VCYT | 65,970 | $2.8M |
Shares reported on the most recent Form 4, priced at the 2022-12-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VCYT | SELL · 10b5-1 | 2022-12-06 | 2022-12-08 | $27.03 | $28K | -1.3% | -14.1% | -11.5% |
| VCYT | SELL · 10b5-1 | 2022-11-11 | 2022-11-15 | $29.34 | $59 | -10.6% | +0.2% | -11.1% |
| VCYT | SELL · 10b5-1 | 2022-11-04 | 2022-11-08 | $25.00 | $26K | +5.7% | +9.3% | +4.0% |
| VCYT | SELL · 10b5-1 | 2022-08-05 | 2022-08-09 | $26.54 | $27K | -14.4% | -23.5% | -2.4% |
| VCYT | SELL · 10b5-1 | 2022-03-04 | 2022-03-07 | $24.91 | $425K | +10.2% | +7.4% | -30.6% |
| VCYT | SELL | 2022-03-04 | 2022-03-09 | $25.03 | $1.0M | +6.8% | +1.2% | -29.9% |
| VCYT | SELL | 2021-12-06 | 2021-12-08 | $37.71 | $1.2M | -1.4% | -19.4% | -39.5% |
| VCYT | SELL | 2021-09-07 | 2021-09-09 | $50.53 | $1.3M | -0.5% | -15.9% | -14.6% |
| VCYT | SELL | 2021-06-23 | 2021-06-25 | $39.75 | $348K | -12.8% | -13.8% | +19.7% |
| VCYT | SELL | 2021-06-04 | 2021-06-08 | $34.63 | $629K | +7.9% | +9.1% | +47.0% |
| VCYT | SELL | 2021-03-04 | 2021-03-08 | $49.23 | $5.0M | +6.2% | +11.1% | -25.6% |
| VCYT | SELL | 2020-12-04 | 2020-12-04 | $56.88 | $1.6M | -17.9% | -18.9% | -19.6% |
| VCYT | SELL | 2020-10-06 | 2020-10-07 | $35.21 | $88K | +9.8% | +13.5% | +27.5% |
| VCYT | SELL | 2020-09-04 | 2020-09-08 | $31.11 | $437K | +7.8% | +27.4% | +104.0% |
| VCYT | SELL | 2020-07-31 | 2020-08-04 | $35.33 | $707K | +10.8% | +6.9% | +14.8% |
| VCYT | SELL | 2020-07-13 | 2020-07-14 | $29.68 | $966K | +1.2% | +16.1% | +39.4% |
| VCYT | SELL | 2020-06-03 | 2020-06-04 | $26.22 | $566K | +1.4% | +10.6% | +32.2% |
| VCYT | SELL | 2020-03-03 | 2020-03-04 | $25.39 | $1.7M | -23.8% | -20.8% | +5.7% |
| VCYT | SELL | 2019-12-05 | 2019-12-09 | $29.39 | $1.9M | +2.5% | -4.1% | -15.3% |
| VCYT | SELL | 2019-12-03 | 2019-12-04 | $26.47 | $811K | +2.8% | -6.9% | -12.5% |
| VCYT | SELL | 2019-11-27 | 2019-12-02 | $29.36 | $217K | +7.1% | +3.0% | -2.3% |
| VCYT | SELL | 2019-09-03 | 2019-09-05 | $25.26 | $716K | -0.5% | -10.1% | +7.8% |
| VCYT | SELL | 2019-08-12 | 2019-08-14 | $25.39 | $1.6M | +0.8% | +3.0% | -5.1% |
| VCYT | SELL | 2019-03-04 | 2019-03-05 | $20.24 | $357K | +10.4% | +30.2% | +12.6% |
| VCYT | SELL | 2019-02-28 | 2019-03-04 | $20.42 | $737K | +1.4% | +19.6% | +6.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.